Skip to main content

Table 1 Proportion of ICU physicians estimating the different potential indications of high-flow nasal cannula therapy as “good” or “very good”

From: High-flow nasal cannula therapy: clinical practice in intensive care units

  Overall, % (n) Seniors, % (n) Juniors, % (n) p*
Hypoxemic ARF 100 (111/111) 100 (68/68) 100 (43/43) 1
  Pneumonia 98 (109/111) 97 (66/68) 100 (43/43) 0.52
  Thoracic trauma 91 (100/110) 90 (60/67) 93 (40/43) 0.74
  Pulmonary embolism 85 (94/110) 87 (58/67) 84 (36/43) 0.78
  ARDS 71 (78/110) 67 (45/67) 77 (33/43) 0.39
  Acute pulmonary edema 57 (63/111) 74 (50/68) 30 (13/43) < 0.0001
  Acute severe asthma 40 (44/109) 45 (30/67) 33 (14/42) 0.32
“Do not intubate” patients 92 (100/109) 90 (60/67) 95 (40/42) 0.48
Per bronchoscopy 92 (97/106) 91 (58/64) 93 (39/42) 1
Preoxygenation before ETI 84 (86/102) 81 (51/63) 90 (35/39) 0.28
Post-operative ARF 76 (80/105) 77 (50/65) 75 (30/40) 0.82
Post-extubation ARF treatment 70 (74/105) 70 (45/64) 71 (29/41) 1
Post-extubation ARF prevention 44 (39/89) 45 (25/56) 42 (14/33) 1
Hypercapnic ARF 33 (27/83) 29 (15/52) 39 (12/31) 0.47
  Bronchial dilatation 32 (35/108) 27 (18/67) 41 (17/41) 0.14
  Thoracic wall deformity 32 (35/111) 30 (19/68) 37 (16/43) 0.40
  COPD exacerbation 28 (31/110) 22 (15/67) 37 (16/43) 0.13
  Acute pulmonary edema 25 (28/111) 31 (21/68) 16 (7/43) 0.12
  Neuromuscular disease 20 (22/111) 19 (13/68) 21 (9/43) 0.81
  Obesity hypoventilation syndrome 19 (21/111) 16 (11/68) 23 (10/43) 0.46
  Acute severe asthma 14 (15/111) 15 (10/68) 12 (5/43) 0.78
  Obstructive sleep apnea syndrome 7 (8/110) 6 (4/67) 9 (4/43) 0.71
  1. ARF: Acute respiratory failure; ARDS: Acute respiratory distress syndrome; COPD: chronic obstructive pulmonary disease; ETI: endotracheal intubation. HFNC: high-flow nasal cannula; ICU: intensive care unit
  2. *Comparisons were performed between junior and senior ICU physicians